Outcome of Board Meeting

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 12 October 2026 National Stock Exchange of India Limited BSE Limited NSE Code: SUNPHARMA BSE Code: 524715 Outcome of the Board Meeting held today, i.e., 12 October 2026 Further to the communication dated 07 October 2026, this is to inform that the meeting of the Board of Directors of the Company (“Board”) was held today, i.e. 12 October 2026, which commenced at 05:00 P.M. and concluded at 05:50 P.M., IST. The Board, inter alia, considered and approved the following: 1. Issuance of Non-Convertible Debentures The Board of Directors has approved the issuance of listed, rated, unsecured, redeemable non- convertible debentures ("NCDs"), on a private placement basis, in one or more tranches and/or series, for an aggregate amount not exceeding INR 10,000 Crore. The Board has also approved the related issuance framework and authorised the Finance Committee to determine and approve the tranche-specific terms and conditions of the NCDs, including matters relating to their issuance, allocation and allotment, within the framework approved by the Board. The disclosures required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 shall be made at the appropriate stage, upon issuance and/or allotment of the NCDs. 2. Resignation of Mr. Gautam Doshi Mr. Gautam Doshi (DIN: 00004612) has tendered his resignation as a Non-Executive, Independent Director of the Company with effect from 12 October 2026, citing personal reasons. He has confirmed that there are no material reasons for his resignation other than those stated in his resignation letter. Consequent upon his resignation, he has also ceased to hold positions on the Committees of the Board of Directors of the Company. The Board of Directors has taken note of the resignation of Mr. Gautam Doshi and placed on record its sincere appreciation for the valuable guidance and contributions made by him during his tenure as an Independent Director of the Company. The details required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are provided in Annexure A and the resignation letter of Mr. Gautam Doshi is enclosed herewith as Annexure B. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 Annexure A Disclosure under Para (A) of Part (A) of Schedule III to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Sr. Particulars 1 Name Mr. Gautam Doshi (DIN: 00004612) 2 Reason for change viz. resignation Resignation from the position of Non- Executive Independent Director of the Company with immediate effect due to his personal commitments. 3 Date of cessation 12 October 2026 4 Brief profile (in case of appointment); Not Applicable 5 Disclosure of relationships between directors (in Not Applicable case of appointment of a director) 6 Letter of resignation along with detailed Enclosed as Annexure B reason for resignation 7. Names of listed entities in which the resigning Not Applicable director holds directorships, indicating the category of directorship and membership of board committees, if any 8. The independent director shall, along with the Mr. Gautam Doshi confirmed that there detailed reasons, also provide a confirmation that are no material reasons for his there are no other material reasons other than resignation other than those mentioned those provided in her resignation letter. Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Annexure B